Status:
ACTIVE_NOT_RECRUITING
Treatment Outcomes of Retroperitoneal Sarcoma
Lead Sponsor:
Taichung Veterans General Hospital
Conditions:
Retroperitoneal Sarcoma
Eligibility:
All Genders
20+ years
Brief Summary
Investigators tried condult a retrospective study to analysis the prognostic factors and oncological outcome analysis of Retroperitoneal Sarcoma treated in our high volume medical center.
Detailed Description
Retroperitoneal Sarcoma (RPS) which is a rare disease which incidence is 1.79/100,000. The treatment is difficult to due to it anatomy position which often invade to multiple organs and cause the comp...
Eligibility Criteria
Inclusion
- the patient who have retroperitoneal maliganacy and receive complete tumor excision in our hospital
Exclusion
- the patient did not receive complete tumor excision in our hospital
- the pathological report yielded not malignancy tumor
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06612671
Start Date
October 1 2023
End Date
September 30 2025
Last Update
September 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taichung Veterans General Hospital
Taichung, Taiwan